Le mardi, Novartis AG (NYSE:NVS) a déclaré des bénéfices trimestriels mitigés, l'estimation de la valeur du deal Avidity Biosciences d'une valeur ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results